PHATHOM PHARMACEUTICALS, INC. (PHAT) Total liabilities 2022–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) total liabilities at each fiscal year-end, per SEC filings.
$697.3MFY2025 · since FY2022: $239.6M → $697.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $697.3M | +10.4% |
| FY2024 | $631.9M | +29.9% |
| FY2023 | $486.6M | +103.1% |
| FY2022 | $239.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAT financial trends
PHAT RevenuePHAT Net incomePHAT Net marginPHAT Gross profitPHAT Gross marginPHAT Operating incomePHAT Operating marginPHAT Operating cash flowPHAT Free cash flowPHAT Capital expendituresPHAT Return on equityPHAT Stock buybacksPHAT Dividends paidPHAT Total assetsPHAT Shareholders’ equityPHAT overview →